Pacific Biosciences Of California (PACB) Research & Development (2010 - 2026)

Pacific Biosciences Of California's Research & Development history runs 17 years deep, the most recent figure standing at $19.6 million for Q1 2026.

• In Q1 2026, Research & Development fell 32.51% year-over-year to $19.6 million; the TTM figure through Mar 2026 stood at $87.9 million (down 27.1% YoY), while the FY2025 annual figure was $97.3 million, down 27.88% from the prior year.
• Research & Development was $19.6 million for Q1 2026 at Pacific Biosciences Of California, down from $22.9 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $52.9 million in Q1 2022 to a low of $19.6 million in Q1 2026.
• Historically, Research & Development has averaged $37.2 million across 5 years, with a median of $42.6 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Research & Development jumped 157.63% in 2022, then tumbled 46.3% in 2024.
• A 5-year view of Research & Development shows it stood at $42.6 million in 2022, then rose by 4.51% to $44.5 million in 2023, then plunged by 38.34% to $27.5 million in 2024, then retreated by 16.7% to $22.9 million in 2025, then retreated by 14.3% to $19.6 million in 2026.
• The last three Research & Development figures came in at $19.6 million (Q1 2026), $22.9 million (Q4 2025), and $22.8 million (Q3 2025), per Business Quant data.